Brief: Erytech Pharma Says Akkadian Has Initiated Proceedings To Postpone Vote On Merger With Pherecydes
05/06/2023 08:27
June 5 (Reuters) - Erytech Pharma ERYP.PA :
* ERYTECH ANNOUNCES THAT AKKADIAN HAS INITIATED PROCEEDINGS
TO
POSTPONE THE VOTE ON THE MERGER WITH PHERECYDES
* AKKADIAN IS ALSO REQUESTING APPOINTMENT OF A LEGAL EXPERT
TO
REVIEW TERMS OF MERGER
* INTENDS TO OBTAIN DISMISSAL OF THIS LEGAL ACTION, WHICH IT
CONSIDERS UNFOUNDED, AND THUS ENABLE ITS SHAREHOLDERS TO VOTE ON
MERGER WITH PHERECYDES ON JUNE 23
Source text for Eikon: ID:nGNE7TzfKY
Further company coverage: ALPHE.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Pherecydes Pharma SA
See all newsBrief: Erytech And Pherecydes Announce Merger And Name Change To Phaxiam Therapeutics
Brief: Pherecydes Pharma SA - Pherecydes Pharma And Erytech Pharma Shareholders Approve Merger Between Two Companies To Create Phaxiam Therapeutics
Brief: Erytech Announces That The Commercial Court Has Rejected Akkadian's Request To Postpone The Vote On The Merger With Pherecydes Pharma
Brief: Erytech: urges shareholders to vote for merger with Pherecydes and dismisses Akkadian's moves
Brief: Erytech Pharma Says Akkadian Has Initiated Proceedings To Postpone Vote On Merger With Pherecydes